Researchers in Japan measured salivary human herpesvirus HHV-6 and HHV-7 and found they can be used as biomarkers to tell the difference between physiological (recovers with rest) fatigue and pathological fatigue.
by Sasha Nimmo A recent paper begins “there has been considerable controversy regarding how to name and define the illnesses known as myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS).” ‘Case definitions integrating empiric and consensus perspectives‘ by Jason, McManimen Sunnquist, Brown, Furst, Newton & Strand was published in Fatigue: Biomedicine, Health and Behaviour. ‘Empiric’ means … Continue reading Study says scientists must agree on classifying patients
by Sasha Nimmo UK’s National Health Service collaboration between university and hospitals will hopefully trial drugs for muscle abnormality in chronic fatigue syndrome (Fukuda criteria) patients. Initial findings revealed that CFS patients developed twenty times more acid in their muscles than those without the illness. Patients in the United Kingdom’s north east could benefit from … Continue reading UK drug trials may help muscle defects in chronic fatigue syndrome patients
by Sasha Nimmo Drug company research team identifies which CFS patients may respond best to Ampligen. Hemispherx Biopharma has identified new criteria to see which CFS patients may get significant clinical benefit from Ampligen (rintatolimod). Patients who are able to complete more than 9 minutes of exercise (modified Bruce protocol exercise tolerance test) are likely to benefit from Ampligen. Data from a previous Phase … Continue reading Treadmill test shows how Ampligen may help